A business in context
NVAX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-20 | Rodgers Richard J | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | Rodgers Richard J | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-20 | King Rachel K. | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | King Rachel K. | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-20 | DOUGLAS RICHARD | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | DOUGLAS RICHARD | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-20 | MCGLYNN MARGARET G | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | MCGLYNN MARGARET G | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-20 | MOTT DAVID M | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | MOTT DAVID M | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-20 | Alton Gregg H | M · Exercise / conversion | Common Stock | 18880.0 | — |
| 2026-06-20 | Alton Gregg H | M · Exercise / conversion | Restricted Stock Units | 18880.0 | 0.0 |
| 2026-06-18 | Rodgers Richard J | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | Rodgers Richard J | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | King Rachel K. | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | King Rachel K. | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | DOUGLAS RICHARD | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | DOUGLAS RICHARD | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | MCGLYNN MARGARET G | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | MCGLYNN MARGARET G | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | MOTT DAVID M | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | MOTT DAVID M | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | Alton Gregg H | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | Alton Gregg H | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | Shiver John W. | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-06-18 | Shiver John W. | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | Newton Charles W. | A · Grant / award | Restricted Stock Units | 14180.0 | 0.0 |
| 2026-06-18 | Newton Charles W. | A · Grant / award | Stock Option (Right to Buy) | 21270.0 | 0.0 |
| 2026-04-25 | Newton Charles W. | M · Exercise / conversion | Common Stock | 9520.0 | 0.0 |
| 2026-04-25 | Newton Charles W. | M · Exercise / conversion | Restricted Stock Units | 9520.0 | 0.0 |
| 2026-04-14 | Walker Robert Edward | A · Grant / award | Stock Option (Right to Buy) | 99500.0 | 0.0 |
| 2026-04-14 | Walker Robert Edward | A · Grant / award | Restricted Stock Units | 66000.0 | 0.0 |
Identity & relationships
SEC issuer · 0001000694NOVAVAX INC
Praha Vaccines
- Legal Entity Identifier
- 529900J4GJHPEPQ23205
- GLEIF legal name
- Novavax, Inc.
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2025-06-22T13:30:02Z
Search names and former names
View Wikidata identity and references ↗
- Novavax · alias · wikidata
- Novavax (United States) · alias · wikidata
- Praha Vaccines · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $682.16M | $726.13M |
| 2023-12-31 | $983.71M | $1.08B |
| 2022-12-31 | $1.98B | $2.26B |
| 2021-12-31 | $1.15B | $1.41B |
| 2020-12-31 | $475.60M | $613.61M |
| 2019-12-31 | $18.66M | $24.37M |
| 2018-12-31 | $34.29M | $45.59M |
| 2017-12-31 | $31.18M | $42.47M |